You have no items in your cart.
Xpovio Open to Advanced Myeloma Patients Outside US via Access Program
Myeloma Research News
People with advanced multiple myeloma and diffuse large B-cell lymphoma (DLBCL) will soon be able to access Xpovio (selinexor) outside the U.S. through a managed access program. This program, also known as ... Read more